Repositioning Candidate Details
| Candidate ID: | R0711 |
| Source ID: | DB05130 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | INCB3284 |
| Synonyms: | -- |
| Molecular Formula: | -- |
| SMILES: | -- |
| DrugBank Description: | INCB3284 is a CCR2 antagonist for Inflammation-driven Diseases. |
| CAS Number: | -- |
| Molecular Weight: | |
| DrugBank Indication: | Investigated for use/treatment in inflammatory disorders (unspecified). |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | C-C chemokine receptor type 2 |
| Inclusion Criteria: | Target associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs | |
|---|---|---|---|---|---|
| S05 | Anti-inflammatory | inflammatory | Bile acid; TNF-a inhibitor; Dual PPAR-α and -δ agonists; Toll-Like Receptor; (TLR)-4 antagonist; Caspase inhibitor; ASK-1 inhibitor | Ursodeoxycholic Acid; Pentoxifylline; Elafibranor; JKB-121; Emricasan; Selonsertib; | Details |
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|